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1.  IntroductIon                 
Organophosphorous (OP) compounds find out wide range 
of applications mainly in agriculture settings and chemical 
warfare1. These compounds have distinct advantages as they 
are relatively easy to make, and biodegradable readily by 
hydrolysis. Over the years, extensive efforts were carried out 
to evolve new OP agents as pesticides and chemical weapon. 
Their residues creates potential hazards for human health due 
to blocking of neural transmission by permanently binding 
with acetyl cholinesterase enzyme resulted in the paralysis and 
mortality2,3. These toxic compounds are generally degraded 
by hydrolysis to first produce alkyl alkyl phosphonic acids 
(AAPAs) and secondly alkyl phosphonic acids (APAs)4. 
O-isopropyl methylphosphonic acid (IMPA) and methyl 
phosphonic acid (MPA) (Fig. 1) are some hydrolytic degradation 
product of OP compounds which exerts deleterious effect on 
the atmosphere and human health. Current analytical methods 
using gas and liquid chromatography for the detection of small 
molecular residues (Mw < 1000) like IMPA are sensitive and 
reliable5. However, they are costly and time-consuming due to 
the complicated sample preparations and derivatisation steps6-10. 
Therefore, there is a growing demand for more rapid and less 
costly methods for determining small molecular residues in the 
environmental sample. Enzyme-linked immunosorbent assay 
(ELISA) is the alternative technique widely used and accepted 
due to its sensitivity, fastness, and cost-effectivity for the 
identification of chemicals like pesticides11–15. 
To achieve better performance of antibody, enzyme 
tracer and analyte, incubation strategy has been chosen so that 
analyte can compete strongly even in the low concentration. 
Similarly, to achieve optimum conditions for the competition 
the conjugated hapten should have less affinity to antibody than 
that of analyte. Additionally the catalytic activity of hapten-
enzyme conjugate is also of great importance16. Considerable 
variations in the affinity, owing to the hapten structures, 
have been reported between homologous and heterologous 
ELISA17–18. In case of homologous ELISA less sensitivity has 
been observed because of strong interaction between antibody 
and enzyme conjugate. 
The Effect of ELISA format and spacer of enzyme 
conjugate both were found to play an important role in order 
to improve the sensitivity of immunoassay19–20. There are 
two kinds of assay formats, with either immobilised antigen 
or antibody. It was observed that in the antigen-immobilised 
format, varying lengths of spacer arm of the coating antigen 
had significant effect on the sensitivity of ELISA. A remarkable 
improvement in the sensitivity of ELISA has been observed 
by various workers using heterology in spacer structure of 
coating antigen21–24. The use of long flexible chains of highly 
hydrophilic polyethylene glycol (PEG) for the preparation of 
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Figure 1. Structure of Sarin, O-isopropylmethylphosphonic 
acid (IMPA), Methyl phosphonic acid (MPA).
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coating antigen was also been found to be helpful in order to 
improve the sensitivity by facilitating the aqueous solubility 
of hapten, thereby greatly improving protein conjugation. 
Studies on the effect of spacer length in enzyme conjugate has 
been studied at length however, not much reports are available 
discussing the effect of ELISA format and spacers on assay 
sensitivity. 
We are engaged in the development of methods for the 
retrospective detection of OP toxicant and their markers. In 
our previous work25 we reported the production of polyclonal 
antibodies against the marker of OP toxicant sarin. The 
obtained antibodies were incorporated into indirect ELISA and 
tested for assay sensitivity towards sarin and its marker IMPA. 
The inhibitory concentration 50 per cent (IC50) of free antigen 
was found to be 0.415 µg mL−1 and limit of detection (LOD) 
was found to be 0.05 µgmL−1. In the present studies antibodies 
having best binding properties have been used to develop more 
sensitive ELISA using horseradish peroxidase (HRP) tracers. 
The aim of the present work was to demonstrate effect of ELISA 
format and Effect of hydrophobic and hydrophilic spacer-
containing OP enzyme conjugates on functional parameters 
on ELISA using IMPA as a model compound. For present 
studies polyclonal anti-IMPA antibody (OP-Ab) was prepared 
in our laboratory from immunogen conjugate 4-(4(isopropoxy 
(methyl)phosphoryloxy)phenylamino)-4-oxobutanoic acid-
bSA25.
2.  MAtErIALS And MEtHodS
2.1 reagents
Reagents were obtained from Sigma-Aldrich (Poole 
UK) unless stated otherwise, including Goat antirabbit IgG 
peroxidase and Horseradish Peroxidase (HRP). Solvents used 
were of analytical grade for synthesis. Monitoring of chemical 
reactions, chromatographic purification and various buffers 
used in the present studies was similar to the earlier studies 
described else where25.
2.2 Instrumentation
The instruments used in the present studies similar to the 
instruments used in the earlier studies described  else where25.
2.3 Synthesis of Hapten derivatives
Suitable hapten derivates (2-5) were synthesised by 
following scheme 1. Four haptens were synthesised by 
reaction of chlorosarin with different amino acids and 
peptides. Consequently, incorporation of 2-aminoacetic 
acid, 4-aminobutyric acid, dipeptides (NH2-phe-lle-COOH, 
NH2-phe-glu-COOH) as a linker to O-isopropyl methyl 
chlorophosphate group was achieved.
2.3.1 Synthesis of OP-1, OP-2, OP-Pep-1, OP-Pep-2
To a stirred solution of 1 (6.4 mmol) in 5 mL of methanol, 
15 mL of methanol solution having KOH (16 mmol) and 
amino acid (8.9 mmol) was added drop wise. Reaction mixture 
was stirred for 10 min at room temperature followed by 
filtration and extraction with 1 M HCl-chloroform. The filtrate 
was dried over anhydrous sodium sulfate and the solvent 
was evaporated under vacuum. The residue was subjected to 
column chromatography using silica gel (hexane: ethyl acetate, 
8:2) to give 5 as viscous liquid (50 per cent yield). 
2.3.2 Preparation of OP-1-HRP, OP-2-HRP, OP-
Pep1-HRP and OP-Pep2-HRP
The IMPA derivatives with carboxylic end group (OP-1, 
OP-2, OP-Pep1 and OP-Pep2) were conjugated to HRP enzyme 
by the N-hydroxysuccinimid ester method. To prepare the stock 
solution N-hydroxysuccimide (2.3 mg, 20 µmol) and N-(3-
dimethylaminopropyl)-N-ethylcarbodiimide (20 mg EDAC) 
were added to a solution of OP-1, OP-2, OP-1-Pep1, and OP-
1-Pep2 (10 µmol) in DMF (2000 µL). The mixture was gently 
stirred at room temperature for overnight. The HRP solution 
(9.68 mg mL-1; 0.22 µmol mL-1) was prepared in 0.13 mol. L-1 
NaHCO3 (1000 µL). For preparing the conjugate 0.22 µmol 
(44 µL) of activated hapten was taken from the stock solution 
in a vial and added 200 µL (0.022 µmol) of HRP solution. The 
conjugation mixtures was kept at room temperature for 4 h, and 
purified by gel filtration chromatography where hapten-protein 
conjugates were passed through PD10 column in presence 
of eluent (100 mM phosphate buffer, pH 7.4). Finally the 
conjugates were stored at -20 °C. The degree of coupling was 
determined by TNbSA assay calculated at 335 nm, comparing 
absorbance value of protein before and after conjugation.
2.3.3 Preparation of OP-1-Urea-HRP, OP-1-ADH-
HRP, OP-1-ODA-HRP and OP-1-BODA-HRP
It was achieved in two steps:
(a) Coupling of spacers (urea, ADH (adipic acid dihydrazide) 
and oxy diamine) to HRP: To the 20 mg mL-1 aqueous 
solution of HRP (lot number 28H7848), NHS (40 mg) 
and EDAC (80 mg) were added and the reaction mixture 
Scheme 1. reaction scheme for the synthesis of hapten derivates oP-1, oP-2, oP-Pep-1, and oP- Pep-2.
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was kept at 4 °C for overnight to activate the carboxylic 
group of HRP. After activation, an amount of 100 µL was 
taken and added into three different vials respectively. To 
this 0.23 µmol of each urea/ADH/oxy diamine in 300 µL 
of ammonium carbonate (used for urea and ADH)/DMF 
(for oxy diamine) was added. The solutions were kept 
at 4 °C for 24 h to allow the HRP-CO-NH-spacer bond 
formation. All the solutions were then dialysed separately 
against 3–4 changes of water.
(b) Coupling of OP-1 to HRP-urea, HRP-ADH and 
HRP-oxy diamine: To prepare the stock solution 
N-hydroxysuccimide (2.3 mg, 20 µmol) and N-(3-
dimethylaminopropyl)-N- ethylcarbodiimide (20 mg, 
EDAC) were added to a solution of OP-1(15 µmol) in 
DMF (1000 µL). The reaction mixture was kept for 24 h 
at 4 °C for activation. After activation 100 µL was taken 
and added to the above prepared HRP-spacer solutions 
(500 µL). The reaction mixtures were incubated at 
4 °C for overnight. The formed tracers were also purified 
by gel filtration chromatography as described in the 
previous section.
2.4 competitive Inhibition Enzyme-linked 
Immunosorbent Assay 
The assay was performed in two formats. In case of 
format I the microtiter plates were coated directly with the 
OP-Ab (1:2000) and the HRP tracer was used in the dilution 
of 1:4000. Whereas, in case of format II plates were coated 
first with the goat anti-rabbit IgG (0.5 µg mL-1, 250 µL well-1) 
at the concentration of 1:5000 and subsequently with OP-Ab 
(scheme 2). The assay utilised HRP tracer in the dilution of 
1:10000. The inhibition curves were run with dilutions of OP-
Ab. The 96-well microtiter plates (Nunc) were coated with 
OP-Ab/ trapping antibodies (goat anti-rabbit, 100 µL well−1) 
in 0.5 M carbonate buffer (pH 9.6) and incubated overnight 
at 4 °C. On the following day, plates were washed three times 
with PBST (PBS buffer containing 0.05 per cent Tween 20, pH 
7.6). For running assays in formats I and II the standard in PbS 
(100 µL) and tracer in PBS (100 µL) were added into the wells. 
The plate was shaken on a microtiter plate shaker for 1 min, 
followed by 1 h incubation at 4 °C. Plates were rinsed five times 
with PBST after each coating and after the competition step to 
remove the unbound immunoreactives. Then 50 µL per well 
of substrate solution was added and the reaction was stopped 
after 15 min by adding 50 µL of 4 M H2S04. The absorbances 
were measured at 450 nm. Standards were run in triplicate. All 
inhibition curves were calculated by the four-parameter logistic 
equation, with the color reaction being inversely proportional 
to the IMPA concentration. Data analysis was performed by 
normalising the absorbance using the per cent B/B0 = (A-Aex/A0-
Aex) X 100, where A is absorbance, A0 is absorbance at zero dose 
of analyte, and Aex is absorbance at an excess of the analyte.
2.5 Analysis of Spiked Sample
To study the spike recovery the same procedure has been 
used as reported earlier by our group26 . Stock solution of IMPA 
(1 mg mL-1) was prepared in methanol. Working standard (50 
µg mL-1) of IMPA was prepared by drawing 100 µL aliquot from 
above prepared stock solution and adjusting to 2.0 mL with 10 
per cent methanol in PBS (10 mM). Tap water was collected 
and spiked with IMPA standards (10 ng mL-1, 50 ng mL-1, 
and 100 ng mL-1). All the prepared samples and the control 
were allowed to stand overnight at room temperature before 
analysed by ELISA and GC-MS. For GC-MS analysis, samples 
were derivatised by tert-butyldimethylsilylchloride (TBDMS) 
and analysed. Similarly, an environmental soil sample was also 
collected from top soil outside the laboratory. A 2 g soil sample 
was spiked with IMPA in various concentrations (10 ng mL-1, 
25 ng mL-1, and 70 ng mL-1). It was extracted with alkaline 
water (pH 10, adjusted with 0.1 M NaOH) and subjected to 
solid phase extraction. For GC-MS analysis samples were 
derivatised by TbDMS.
3.  rESuLtS And dIScuSSIon 
Hapten synthesis is very significant step in the 
development of immunoassay as it is responsible for getting 
antibody possessing excellent affinity towards target analyte. 
Haptens were synthesised by nucleophilic displacement 
of chlorine with amino group of amino acids or peptides. 
These hapten were insufficient in eliciting immune response, 
therefore high molecular weight carrier protein such as HRP 
was required to attach with synthesised haptens. To prepare 
the hapten-HRP conjugates, two conjugation procedure was 
adopted according to the functionalities present in the hapten 
derivative.The IMPA derivatives with carboxylic end group 
(OP-1, OP-2, OP-Pep-1, and OP-Pep-2) were conjugated to 
HRP enzyme by the N-hydroxysuccinimide ester method27. 
Coupling of spacers like urea, adipic acid dihydrazide (ADH) 
and oxy diamine to HRP was achieved in two steps as shown 
in scheme 3. In the first step carboxylic acid group of HRP 
was conjugated to spacer through amino functionality utilising 
the same N-hydroxysuccinimide ester method. In the second 
step HRP-spacer were conjugated to OP-1. All the conjugates 
(Table 1) were kept at room temperature for 4 h, and purified 
by gel filtration chromatography (Sephadex PD-10, Amersham 
Pharmacia, Freiburg, Germany).
The free amino groups in the HRP before and after 
the conjugation were determined by reaction with 2,4,6-
trinitrobenzenesulfonic acid (TNbSA). Reaction of primary 
amines with TNBSA forms a highly chromogenic trinitrophenyl 
derivative that can easily be quantified by colorimetric read-
out at 335 nm. The degree of hapten conjugation to HRP was 
Scheme 2. cIELISA: A schematic representing both the ELISA 
formats
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calculated from the absorbance values at 335 nm (which is 
the characteristic absorption peak of the trinitrophenol group 
(TNP) using the following equation:
Substitution (%) = [Acontrol− Aconjugate)/Acontrol] × 100.
Control experiments were performed in parallel and 
consisted of protein mixed with hapten without 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC.HCl). Considering 
three dimensional structure of HRP, six ε-NH2 groups of 
lysine residues are available for coupling to haptens. Hapten 
density found to be in all the hapten-HRP conjugates was in 
the range of 2 to 4. Conjugates were additionally characterised 
by MALDI- MS. The molecular weight of native of the HRP 
enzyme was determined to be 43000 da. The relative increase 
in molecular weight of conjugates was manifested as a gradual 
mass peak shift as a function of hapten to enzyme ratio. This 
is interpreted as an increase in hapten density of conjugates 
and therefore provides a method for determining number of 
haptens per enzyme molecule. The findings of MALDI-MS 
analysis in terms of hapten density were in close agreement 
with data obtained from the TNBSA spectrophotometric 
method of analysis.
All the tracers were used in the same dilution of 1:5000. 
The dose response study of the seven enzyme conjugates (entry 
1 to 8) was carried out with OP-Ab using competition inhibition 
ELISA (Fig. 2). All enzyme conjugates differing from each 
other in terms of spacers. OP-1-HRP conjugate was considered 
as reference to the assay. OP-2-HRP, OP-Pep1-HRP and OP-
1-ADH-HRP conjugates were having hydrophobic spacers. 
Hydrophilic and flexible spacers were used for preparing OP-
1-ODA-HRP and OP-1-bODA-HRP conjugates. In contrast to 
other conjugates OP-Pep2-HRP conjugate included hydrophilic 
spacers. The assay sensitivity was expressed in terms of IC50 
(Table 2). It is the effective concentration at which 50 per cent 
of inhibition in the binding of enzyme conjugates occurs in 
assays in the presence of analyte.
From the Table 2 it was evident that spacers played a 
significant part in the free analyte recognition. The insertion 
of hydrophilic spacers in OP-Pep2-HRP conjugate enhanced 
the sensitivity significantly. The finding was also supported 
by study carried out by Nara19, et al. in which insertion of 
Figure 2. Inhibition curve for IMPA by direct inhibition 
ELISA.
Scheme 3. reaction scheme for the preparation of hapten-HrP 
enzyme conjugates.
table 1. chemical structures of prepared hapten-HrP 
conjugates
Entry Hapten-HrP conjugate code
1 O P N
H
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O
NH-HRP
OP-1-HRP
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O H
N
O
HRP OP-2-HRP
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H
HRP OP-Pep1-HRP
4
O P
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H
H
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NH-HRP
O
NH-HRPO
OP-Pep2-HRP
5 O P
O
NH
O
NH
O
NH
O
HRP OP-1-urea-HRP
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O
OH
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H
N
H
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O P
O
NH
O
O
HRP OP-1-ADH-
HRP
7 NHO P
O
N
H
O
NH
O
HRP
O
OP-1-ODAa-
HRP
8 NHO P
O
N
H
O
O
NH
O
HRP
O
OP-1-bODAb-
HRP
a2,2’-(oxybis(ethylamine) (ODA) b2,2’-(ethane-1,2 diylbis(oxy))diethan-
amine (bODA)
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hydrophilic spacer resulted in the enhancement of sensitivity 
and specificity of assay. Possibly the use of a hydrophilic spacer 
helped in projecting the hapten in the aqueous phase, leading 
to enhanced antibody binding signal and improved sensitivity 
of the assay. The present finding suggests that the nature of the 
spacer (hydrophobic, hydrophilic and amphiphilic) is related to 
assay sensitivity and not to spacer length.
The absorbance was recorded at 450 nm and data 
analysis was performed by normalising the absorbance. The 
concentration of free IMPA was plotted on the X axis and 
percentage of inhibition ( per cent) on the y axis. Data points 
are the means of triplicates. Assay formats greatly Effect the 
sensitivity, absorbance and analysis time of the assay. Two 
ELISA formats were tested; the first involved the direct coating 
of OP-Ab (1:2000) to the microtiter plate where as in the other 
format the plates were precoated with goat anti-rabbit IgG 
(1:5000) were utilised. The comparison of both the formats 
using four enzyme conjugates is presented in Table 2. The use 
of two coating steps (formats II) resulted in higher sensitivity 
compared to the format using one coating step. better results 
were obtained by direct coating of the OP-Ab to the plates 
however; longer substrate incubation time was required for 
equal color development. Moreover, plate-to-plate variation 
was larger than the format II.
Significant lower sensitivity was observed in the 
competition step when antibodies were used in solution in 
comparison to the antibodies immobilised on the plate. This is 
probably due to the higher concentrations of OP-Ab available 
in solution compared to the immobilised antibodies. Therefore, 
appropriate concentrations of tracer and IMPA are necessary for 
an effective competition with the antibodies in solution. As such 
the Effect of spacer was also observed in case of ELISA format 
I, however the use of two sequential coating steps (format II) 
provided the best sensitivity and reproducibility, which can be 
a consequence of high enzyme tracer dilutions. The precoating 
step eliminated the blocking steps (e.g. with BSA) after coating 
from the assay. For construction of the calibration curves IMPA 
stock solution (1 g L-1) was prepared with methanol and then 
further diluted with pure water to obtain individual standard 
solutions ranging from 0.003 µg ml-1 to 250 µg ml-1.
An IC50 and the lower detection limit determined by 
standard inhibition curve (Fig. 2) was found to be 0.01 
µg mL-1 and 0.004 µg mL-1 respectively while OP-1-
Pep2-HRP conjugate was used in ELISA format II. The 
specificity of the assay in format II was estimated as 
the percentage of cross-reaction using OP-Ab antibody. 
The antibodies didn’t show significant cross-reactivities 
for the related compounds (Table 3). Maximum cross 
reactivity was observed with chlorosarin (100 per cent), 
O-pinacolylphosphonic acid (PMPA, 33 per cent) while 
other compounds exhibited least reactivity towards OP-
Ab. The incorporation of hydrophilic spacer in the enzyme 
conjugate (OP-1-Pep2-HRP) has decreased the degree of 
cross-reaction as compared to enzyme conjugates having 
hydrophobic spacer like OP-2-HRP and OP-1-ADH-HRP 
and specificity of OP-Ab with other compounds also 
followed the same trend as obtained in case of enzyme 
conjugate (OP-1-Pep2-HRP). 
As the assay with OP-Pep2-HRP gave better sensitivity 
and specificity, this combination was further studied for 
analytical variables like recovery, precision, and correlation 
coefficients with GC-MS studies.
To investigate the effect of matrix standard curves were 
plotted after spiking IMPA in tap water and soil. The obtained 
lower detection limit with spiked samples was nearly identical 
to the standard one 0.004 µg mL-1. To study the spike recovery, 
environmental water from general water supply was used. 
Tap water and soil samples were spiked with IMPA at various 
concentrations and each spiked sample was analysed in 
triplicate by the same method (ELISA format II). Validation of 
the method was carried out by GC-MS analysis. Table 4 shows 
the recovery of IMPA from the tap water and soil samples 
which was carried out by ELISA (format II) utilising OP-1-
Pep2-HRP followed by comparison with GC-MS studies. The 
IMPA recoveries of the developed ELISA ranged from 92 per 
cent - 118 per cent and were observed in close agreement to 
those obtained through GC-MS analysis (98 per cent - 112 
per cent). This clearly indicates that no significant matrix 
interferences were observed in both the cases. In water samples 
just filtration was sufficient for immunochemical analysis. 
However, extraction followed by sample clean up was required 
in analysing the soil samples.
4.  concLuSIonS
The present study described the effect of assay format and 
the Effect of spacers towards the sensitivity on the detection of 
IMPA by competitive immunoassay. Once a good polyclonal 
or monoclonal antibody is developed it can be employed in 
various formats and sensitivity can be enhanced. The use of 
OP-Ab in solution for the competition step resulted in lower 
sensitivity. It was also observed that the nature of spacer is more 
remarkable factor than the length of the spacer. Hydrophilic 
spacers appear to be more favourable than the hydrophobic 
spacers for enhancing the sensitivity. The incorporation of 
hydrophilic spacer in the enzyme conjugate decreased the 
degree of cross-reaction as compared to enzyme conjugates 
having hydrophobic spacer. These finding are in agreement 
Entry Enzyme conjugate ELISA Format I ELISA Format II
IC50 (µg mL
-1)a Amax. IC50 (µg mL
-1)a Amax
1 OP-1-HRP 11.55 0.33 6.25 1.20
2 OP-2-HRP 8.42 0.30 5.27 0.67
3 OP-Pep1-HRP 10.60 0.29 6.18 0.52
4 OP-Pep2-HRP 0.16 0.42 0.01 0.70
5 OP-1-urea-HRP 0.32 0.48 0.04 0.72
6 OP-1-ADH-HRP 13.34 0.38 7.32 0.64
7 OP-1-ODA-HRP 3.72 0.41 0.78 0.63
8 OP-1-bODA-HRP 3.12 0.38 0.39 0.73
aIncubation time required for color development; OP-1-HRP = 20 min, OP-Pep2-HRP 
= 17 min, OP-1-urea-HRP = 15 min, OP-1-bODA-HRP = 20 min. Inhibition assay was 
carried by direct ELISA using format I and II. The assay utilized HRP tracer in various 
dilution to get the optimum sensitivity. OP-1-HRP 1:2000, OP-Pep2-HRP 1:2000, OP-
1-urea-HRP 1:4000, OP-1-bODA-HRP 1:2000.
table 2. comparison of different ELISA formats using direct coating of oP-
Ab or precoating with goat anti-rabbit IgG
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with the available litreture19,20. The developed assay for the 
detection of IMPA can be used for the direct applications to 
environmental samples. No matrix effects have been observed, 
even when the analysis was done without previous dilution.
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